Serum alkaline phosphatase elevation as a preoperative sarcopenic biomarker in digestive cancer: a retrospective cohort study
- Kohta Asano 1,2, Kae Tachibana 3, Satoru Shinoda 4, Takeshi Nakamura 5
- Kohta Asano 1,2, Kae Tachibana 3, Satoru Shinoda 4
- 1Department of Rehabilitation Medicine, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan. uncle_harry.7@outlook.com.
- 2Department of Neuroanatomy, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan. uncle_harry.7@outlook.com.
- 3Department of Rehabilitation Medicine, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
- 4Department of Biostatistics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
- 5Department of Rehabilitation Science, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
- 0Department of Rehabilitation Medicine, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan. uncle_harry.7@outlook.com.
|
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Elevated serum alkaline phosphatase (ALP) may indicate sarcopenia risk in preoperative digestive cancer patients. This chronic inflammation marker could help identify patients needing intervention before surgery.
Area Of Science
- Oncology
- Gastroenterology
- Geriatrics
- Biochemistry
Background
- Sarcopenia is linked to poor prognosis and postsurgical complications in preoperative patients.
- The mechanism of sarcopenia in cancer patients is not fully understood.
- Chronic inflammation is implicated in sarcopenia development.
Purpose Of The Study
- To investigate if elevated serum alkaline phosphatase (ALP) can serve as a preoperative sarcopenia marker in patients with digestive cancer.
- To explore the association between chronic inflammation, indicated by ALP, and sarcopenia in this patient group.
Main Methods
- Retrospective analysis of electronic medical records from 274 patients with digestive cancer.
- Patients were categorized into sarcopenia (SC) and nonsarcopenia (NSC) groups based on perioperative screening.
- Statistical analysis was performed, accounting for confounders like age, liver function, and bone fractures.
Main Results
- Serum ALP levels were significantly higher in the sarcopenia group (168.4 U/L) compared to the nonsarcopenia group (100.4 U/L).
- Elevated ALP showed a significant correlation with sarcopenia risk (p=0.0018, OR=1.0055).
- Significant differences were observed in albumin, hemoglobin, neutrophil-to-lymphocyte ratio, and malnutrition parameters between groups.
Conclusions
- Serum ALP elevation, potentially due to chronic inflammation, is correlated with sarcopenia in preoperative digestive cancer patients.
- ALP may serve as a useful biomarker for identifying sarcopenia risk in this population.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:30
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
01:24
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.

